Company / Interest Expense
Enveric Biosciences, Inc. Interest Expense History
FY2017-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$729.9K
FY2019
5-year range
$575.0K / $751.1K
FY2017-FY2019
Trend
+26.9%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $751,074 to $729,896 over the past 2 years.
Based on SEC 10-K filings.
$729,896 in FY2019.
Improved from $751,074 to $729,896 over the past 2 years.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2019, interest expense increased 26.9% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2019 | $729.9K | +26.9% |
| FY2018 | $575.0K | -23.4% |
| FY2017 | $751.1K | - |
As of FY2019 · SEC 10-K · Updated Jun 24, 2026